Hans-Peter Volz (H P Volz)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Squamous Cell Carcinoma

Depressive Symptoms

Placebo Controlled

Top Venues

European psychiatry : the journal of the Association of European Psychiatrists

European archives of psychiatry and clinical neuroscience

This page only lists publications with an associated author ORCID identifier.

Publications

Markus Dold, Hans-Jürgen Möller, Hans-Peter Volz, Erich Seifritz, Sandra Schläfke, Lucie Bartova, Siegfried Kasper
Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: A symptom-based, patient-level analysis of randomized, placebo-controlled trials. European psychiatry : the journal of the Association of European Psychiatrists 67 (1) (2024)
Markus Dold, Hans-Jürgen Möller, Hans-Peter Volz, Erich Seifritz, Sandra Schläfke, Lucie Bartova, Siegfried Kasper
Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: A symptom-based, patient-level analysis of randomized, placebo-controlled trials. European psychiatry : the journal of the Association of European Psychiatrists 67 (1) (2024)
Markus Dold, Hans-Jürgen Möller, Hans-Peter Volz, Erich Seifritz, Sandra Schläfke, Lucie Bartova, Siegfried Kasper
Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: A symptom-based, patient-level analysis of randomized, placebo-controlled trials. European psychiatry : the journal of the Association of European Psychiatrists 67 (1) (2024)
Markus Dold, Hans-Jürgen Möller, Hans-Peter Volz, Erich Seifritz, Sandra Schläfke, Lucie Bartova, Siegfried Kasper
Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: A symptom-based, patient-level analysis of randomized, placebo-controlled trials. European psychiatry : the journal of the Association of European Psychiatrists 67 (1) (2024)
Markus Dold, H J Möller, Hans-Peter Volz, E Seifritz, S Schläfke, Lucie Bartova, Siegfried Kasper
Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders - a symptom-based, patient-level analysis of randomized, placebo-controlled trials. European psychiatry : the journal of the Association of European Psychiatrists (2024)
Lucie Bartova, Markus Dold, Hans-Peter Volz, Erich Seifritz, Hans-Jürgen Möller, Siegfried Kasper
Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited. European archives of psychiatry and clinical neuroscience (2022)